OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

ails ~Pa eNo
Foreword .
Statement ofTrustee Responsibilities .
Trustee Report .
Trustee Report Appendices 15
Appendix
A - Schedule
of Charitable Funds
Appendix 8 - Donated Income Policy
Appendix C - Invesnnent Guidelines
Appendix
D - Invested
Pool Guidelines for Restricted Funds
Appendix E - Reserves policy
Appendix
F - General Purpose Guidelines
Financial
Statements
2021/22
25
Statement ofFinancial Activities .. 26
Balance Sheet . 27
Cash flow Report . 28
Notes to the Accounts 29
Auditor's
Opinion .
43

uri ng 202 1/22 the Charitable Funds Conunittee
comprised of;
Ms Mandy Wearne Non-Executive
Director (Committee
Chair) until
31/08/2021
Mr Ibrahim Ismail Non-Executive
Director (Committee
Chair) from
01/09/202 I)
Mr Robert Forster Deputy Chief Executive &Chief Finance ONcer
Ms Dianne Browne Chief Nurse until 03/I 0/2021
Ms Elaine Inglesby-Burke Interim Chief Nurse from 04/10/2021
Mr Tristan Cope Medical Director to 17/10/2021
Mr John Brennan Interim
Medical Director from 18/10/2021

zozt/zz zoz trzz 202mz zol Ia1 2020-21 2010-11 lllls-21 2020 21
Hole I,'nreslridcd
Funds
Rcstriwcd
Funds
Endoament
Feeds
Totalpunds Unresmcied
Funds
Rexuiwcd
Funds
Eadowmcni
Funds
To»i Funds
1000 Koao 1000 1000 1000 rOOD
Income and
Endo»ments
from:
Donations
4't Legacies
2.1 0 1,058 0 1,058 0 1,446 D 1,446
Other Trading
amivities
22 0 0 0 0 0 0 0 0
Investmcnts 2.3 0 229 0 229 D 247 0 247
Tolsl Income 41 Endowments 0 1,287 0 1,287 0 1,693 0 1.693
Expenditure
on:
Raising funds 3 0 501 0 501 0 357 0 357
Charimble
acttvutes
4 0 1,241 D 1,241 0 1,134 0 1,134
Governance 5 0 42 42 0 52 0 52
Taint Expenditure 0 1,784 0 1,784 0 1,543 0 1,543
HctGains / (Losses) on
Invcsnnents
8 0 712 (2) 710 0 1,714 (t) 1,713
Net Income/(Expenditure) 215 (2) 213 1,864 (I) 1,863
Transfers bet»ncn funds 0 0 0
Nel movemenl ln funds 6 0 215 (2) 213 0 1,864 (I) Izmz
Recon ciliat los offunds:
Fund balances carried forward at 31
MARCH 2021 8,249 79 8,328 0 6,385 80 6.465
Fund balances carried for»srd st 31
IIIARCH 2021 8,464 77 8,541 0 8,249 79 IL328

B rmmctcd Rrstdctcd F dnnm nt Total at Unrestn lcd Re Iruled ludonmcnl tulal at
Notes Funds Funds Fumls 31 stnmh Funds Fudt Fu
ds
31 hl
rh
31.93.22 31.93.21 3LD3.22 \D22 I 0121 31 D3 „"I 31 D
21
7tl21
Bion 4900
FHed ameMt
Invettmenlv 8 (I 77 9,70tl D 8911 79 8,990
Total Fixed
AaceLc
0 9,6 3 77 9.700 0 8911 79 8.990
Current
esselst
Stncks 5 0 5
Debtors 10 634 0 634 153 153
Cash at bans and m hand n 1,024 0 1,024 1,396 1,396
Total Current
Assets
0 1,663 D 1,663 D 1,554 0 1,554
Crcdnors
utlhm oae
Amounts
raging due
vear
I I I D 2R 9 0 2,429 0 1.335 0 i.335
.'iel Current
Assets
I 1LlabBltlrst 0 ( 7661 0 17661 0 219 0 219
Total Assets lem Curcent Lishilities 0 8,857 77 82134 0 9,130 79 9.209
Crcrlttora
Amounla
agmg JuC agCr mOIC 393 0 8$1 0 88
iltan onc Fear
Total Nct Assets 0 8,46-1 77 8,541 0 8,249 79 ga28
Funds ofI he Charity
Cantlal Funds.
Endovnnenltundt 0 0 77 77 0 0 7rr 71
Income Funds:
kesniclcd
mcomc funds 125 0 0 $.464 08490 8249
Unrcstncted Bards n n 0
Total charltv fends 0 SN64 77 8.541 0 8.249 79 8,32$

Total Total
2021/22 2020/21
gooo f000
Cash ilows from Operating
Activities:
Net Cash provided
by (used in) operating
activities f601) ~(89II
Cash aows from investing
aetivitiesr
Returns
on Investments
229 247
Piocccds from sale ofinvestments 2,119 3,737
purchase ofInvestments (2,119) (3,229)
Net cash provided
by (used in) investing
activities 229 755
Change
in cash and cash equivalents
(372) (143)
Cash and Cash equivalents
at the start
ofthe year 1,396 1,539
Cash and Cash equivalents
at the end of
the year 1,024 1,396
Reconciliation ofnet income / (expenditure) to net cash t)ow from Operating activities
Net income /(expenditure)
as per the SOFA
213 1,863
Dividends
and Interest from Investments
(229) (247)
(Increase) / decrease in Stocks
(Increase) / decrease in Debtors (481) 25
Increase /(decrease)
in Creditors
606 (827)
(Increase) / decrease
in Investment
Gains /
Losses (710) (1,713)
Net sash (outllew)
/ inoew from operating
nativities (601) (898)

SMusscn Chair
M Eastwood Non Executive Director
TJohnston Non Executive Director
SSsmuels Non Executive Director
Ede Souse Non Executive Director
N Willcox Ncn Executive Director
M Wcemc Ncn Executive Director (to August 2021)
I Ismsil Non Executive Director (from September 2021)
ProfLKenny Non Executive Director (to June 2021)
ProfTWclley Non Executive Dlremcr (from July 2021)
SWsrbuion Chief Executive OAlcer (tcSeptember 2021)
D Dalton Interim Chief Executive OAicer (from September 2021 tu Mny 2022)
I Sumner Chief Executive Onlcer (frcm Msy 2022)
D Brown Chief Nurse (to October 2021)
L' Ingle sby-Burke Interim
Chief Nurse (from October 2021 IcJune 2022)
D Metic Chief Noise (frcm July 2022)
TCope Medical Director (Io October 2021)
J Brennan Inteem Medical Director (from October 2021 to Junc 2022)
J Gerdncr Executive Medical Director (frcm July 2022)
R Forster Deputy Chief Executive Oflicer k.Chief Finance Officer
D Hemng Chief People OAiccr (Io Junc 2022)
BWeston Chief Operating 0Aiccr
Donations ds
Legacies 2.1
1tnreslricted Reslric!Cd Endowment Total
2021-2.2
Funds
2021-22
Fund~
2021-22
Funds
2021-22
Funds
Tatsl
2020.21 Funds
8000 8000 COOO 8000 COOO
Donations 569 1.313
Legacies 489 489 133
Ta1st 0 1,058 0 1,058 1,446
Trading
Activities 2.2
Unrestricted Restricted Endawmeat Total
2021.22
Punds
2021-22
Funds
2021-22
Funds
2021-22
Fuads
TOUt
2020.21 Funds
COOO COOO corn COOO
Fundraising
Tota I 0 0 0 0
Investment
Income 2S
DnreelriClcd
2021-22
Panda
Ralrieled
2021-22
Funds
Endowmeal
2021-22
Fua de
Total
2021-22
Funds
Torsi
2020-2! Funds
6000 COOO COOO 8000
Dividends and inveslmenl interest 227 227 247
Bank Interest
Torsi 0 229 0 229 247
Expenditure on
Raising funds
tinrestrictcd nalrieted Endoumeat Tots I
2021-22
Funds
2021-22
Fuads
2021-22
Funds
2021-22
Fuads
Toml
2020-21 Punds
8000 COIKI COOO COOO
Fundiai sing Costs 442 305
Iiiveslment Management 59 52
To1st 0 501 0 501 357
Expenditure on
Charitable
Activities 4
Durcstwctcd Restricted Eadowmcnt Total
2021-22
Funds
2021-2.2
Funds
2021-22
Funds
2001-22
Fuods
Total
2020.21 Funds
8000 COOO 6000 Com
Psticnu Welt'are &amenities 62 62 77
SMITWelfare n amenities 276 276 733
Remsmts R Educsiio» 325 325 249
Contrittutions lo NHB Capital 578 578 75
Tamt 0 IR41 0 IR41 1.134
Other
Unrestricted
2021-22
Funds
Restricted
2021-22
Funds
Endowment
2021-22
Funds
Total
2021-22
Funds
Total
2020.2( Funds
8000 FOOO f000 5000 5000
Governance 42 52
Total 42 42 52
Allocation and
Apportion
Governance
to Basis of
Allocation
ABoeated to
Governance
Residual for
Apportion
Total
2021-22
Funds
Total
2020-21 Funds
Costs
8000 8000 EOOO 5000
Salaries Time Spent 25 55 80 91
Esmblishmcnt Costs Governance
Audit Fee Governance
Miscegancous Governance l3
Tots I 42 56 98 116

Ax Direct Costs Support
Costs
Total costs
2021-22
Totalcosu
2020-21
5000 00 EOOO KOOO
Expcndimre
on raising Funds.
Fundraismg 430 t2 442 305
Investment
Management
41 18 59 52
Sub - Total 47( 30 501 357
Expenditure
on Chaniable
Activities.
Patients Wcl fare th amenities 61 62 77
StaffWelfare te amen ib es 270 276 733
Research 3(8 325 249
Contributions to NHS Capital 566 12 578 75
Sub - Total (415 26 1,241 1,134
Governance 0 42 42 52
Total Expenditure 1,686 98 1,784 I+43
Charity Grants to Grants Io Support
Activities by Institutions Individuals Costs 2021- Total Tohd
Type SJ 2021-22 2021-22 22 2020-21 2020-21
f000 f000 f000 f000 iOOO
Patients Welfare 41 amenities 61 62 77
Statf Wclferc 4L amenities 191 79 276 733
Rcscarch 318 325 249
Contributions to NHS Capital 566 12 578 75
Total 1,136 79 26 I341 1,134
Grants
awarded to Total Total
insitutions 5,4 2021-22 2020-21
f000 f000
Liverpool University Hospital NIIS FT1
Royal Liverpool' Broadgrccn University 771 794
Hospital s NH STruer
University of Liverpool 365 44
1,136 838
Changes in
Resources Restricted Endowment Total Total
Available for Unrestricted 2021-22 2021-22 2020-21 2020-21
Charity Use 6 2021-22 Funds Funds Funds Funds I unde
f000 EOOD 6000 0000 f000
Net movement In funds for thc year 215 (2) 213 1.863
Net movemem in tangible fixed assets
Net movement in funds available
0 215 (2) 213 1,863
Analysis of
Fixed Asset
Investments 2021-22 2020-21
Ll Fixed Asset Investments: f000 fOOO
Market value at 31 March 2021 8,990 7,785
Less: Disposats at carrying value (2,]19) (3,7371
Add: Acquisitions
at cost
2,]19 3,229
Net gain on revaluation 710 1.713
Market value at 31 March 2022 9,700 8,990
Historic cost at 31 March 2022 8464 7,898
Held in Held outside 2021-22 2020-21
S.2 Market value at 31 March: UK UK Total Total
f000 f000 f000 f000
Investments
listed on the Stock Exchange
8,912 8,912 8,878
Cash held as pan ofthe investment
portlolio
788 788 112
9,700 9,700 8,990
Analysis of 10 Total ss at
31MARCH
Total as at 31
MARCH
Debtors 2022 2021
10.1 Amounts falling due within
one year:
8800 EOOO
Prepsyments
Accrued income 634 151
Total debtors falling due within onc year 153
10.2 Amounts fallingdue over one year:
Total debtors falling duc alter more than one year
Total debtors 634 153
Analysis of TQIBI$5st
31MARCI I
Total as at 31
MARCH
Creditors 2022 2021
11.1 Amounts falling due within one year: KOOO 6000
Other creditors 266 152
Accruals 2,163 1,183
Deferred income
Totol creditors falling due within one year 2,429 1,335
11.2 Amounts falling duc after more than one year:
Accruals 393 881
Total creditors failing aOer more than one year 393 881
Total creditors 2,822 2,216
Analysis of 12
Funds
12.1 Endoumcnt Fuods 31.03.22 Balance 31
March 2021
Ilicotiiiiig
Resources
Rmources
Expended
Transfers Gaim aud
Losses
Bslsnce 31
Iitarch 2012
Gist mdividuslly) f000 f000 fOOD
A M A Device 19 19
B S I V Cooke 15
C DrI Bernstein
D Mr N Gibben 47 (2) 40
Others (I)
Torsi 19 0 (2) 77
Details of 12.2 Nsmeoffund Descriptieu et the nature and purpose ofeach fund
material A MA Device Bed endoivment Cued for Patients Wd fare
fuads- SIVCooke Holiday
fund for Nunes
Endowment DrI Bcrmtein RI.UH Convatcsceme
snd recreanon
fund
Funds 31.03.22 Mt N Gibbon Annual
Urology
Scholarship
12& Endowment Feeds 31,03,21 Bslmce31
March 2020
Iucomiug
Resaurces
Resources
Expended
Transfem Gamsand
Losses
Balsnee31
Alarcb 2021
(list indimduslly) f000 f000 2000 f000
A M A Device 2D 19
B SIVCookc 16
C DrIBcmstcin
D Mr N Gibbon 41 42
Othcm (I)
Total SO 0 (I) 79
Dclai'ls of 12.4 Nameslfuad Descriplioa ofthe nature and purpose ofeach fund
material M A Devise Bed endoumem fund for Patienn Welfare
funds- S I V Cooke Holiday
fund Ibr Nurses
Endowment Dr J Bernstein RLUII Convalesccncc andrecreation
I'uml
Funds 3L03.21 Mr N Gibbon Aunml
Urology
Scholarship
12.4 Rcstrictcd Funds310722 Rcstrictcd Funds310722 Balance 31
Marsh 2021
Incommg
Resources
Resources
Expended
Trsnsfea Trsnsfea Trsnsfea Gains and
Losses
Balaece31
his rch 2021
Balaece31
his rch 2021
hlalcrfal f nd 5000
(licl individually)
A RLIIH Gcncml Purpose 808 372 (298) 255 93 1231
B L'pool Reg Dialysis Fund 747 149 (18) 70 948
C Endocrinology
Fund
22 (16) 6$ 939
D RLUH Pauent
Welfare
Fund 15 (21) 31 515
E St Paul's Fnd. PrevofBlindness 205 461 (283) 69 451
F Forget Mc Not Fund 415 22 (5) (147) 390
G RLUH Renal Transplml Fmd 32$ 13 (6) 0 26 361
tl RLUH Cardiac Fund 283 (19) 22 193
Others (9S) 226 (1,118) (10$) 2$6
Toal 8,249 1287 (f,784) 0 712 gridd
12.6 Name offuad Dcscriptlo
afthe nature and
purpose ofeach fund
RLUH General
Pmpose
Any clmitablc purpose relalieg to Royal Liverpool Unirvmity Hospital
L'pool Reg Dialysis Fmd Any chanablc purpose
cclctmg
to Dialysis seiaces
Endocrinolofy
Fum!
Any cluuiablc purpose
relating
to diseme ofthe gland
RLUH Patients WclCiue Fund For the re lief ofRLUH parim is cuffs nng
Ciom uck
ness snd discase oria effcas
St paul's Fnd. Picv ofBlindnca For the public bcneCit Ophthalmic mscareh mnncaed to RLIJH Sr Paul's Eye Uni!
Forget Mc Nm Fund Any chaimb tcpurpose
relating
to amc crservices
RLUH Renal Tnmiplml Fund Any charitable pmimse relating lo Renal Transplml Unit
RLVH Cardiac Fmd For the relic
C ofpcaons sulfcri
g from cardiac Bream end resen ch into cadisc discase
d F dc 31.03.11 Defence 31
March 2020
Incoming
Rcsourecs
Rcsourccs
Espcndcd
Tinnr km Tinnr km Tinnr km Gans md
Losses
Gans md
Losses
Balance 31
Sfarch 2021
5000 5000 5000 $000
hlsterial funds
(hst mdividmgy)
A Endocnoology
Fund
703 23 (17) 156
0 RLUE General Purpose 5I I 186 (2el) 252
C L'pool Rcg Dialysis Fmd (102) 163 747
D RLBUHTGcncrsl
Purpose
231 1,020 (723) 54
E RLVtlPaiientWelfareFmd 33 (3)
F Forget Me Noi Fund 475 24 (124) 475
G BOH Haematology
Fund
13 (8) 427
H RLUH Renal Tramplsni Fund 266 (6) 59 328
Olhers (98) 2.792 259 HIS) 795 3327
Total 6,385 Idi93 (I.S(3) 0 1.714 8349
Name offund Dacriplion ofthe nature sod pu pose ofeach I 6
Endoerinolegy
Fund
Any ehrritablc purpose relating todIteasc ofthe gland
RLVH General Pmpose Any cluuitablc pmpose rclating ro Royal Livapoof Llni ersity Hospital
L'pool Rcg Dialysis Fu d Any charitable puposc relating io Dialyriit services
RLBUHT General Purpose Any charitable purpose celating lo Royal Livapool 0 Broadgrcen Univ c airy Hospitals
RLVH Patients
Welfare Frmd
For the relief ofRLUH paumrs snE'cring fram sick nem and disease orits ~ffeca
Forget Me Noi Fum! Ai y charitable porpom rctanng ro«anccr savitar
BGH Hacmsrology
Fund
Any charitabl pmposes
relating
lo Haanatology Unit
RLUHRmsl
Trmsplmr
Fuad Any charitable pmpose
n laring
toRenal Tramphmt Unit
Contingcncics Contingcncics 13 There werc no conungent
assets
or liabilities or liabilities or liabilities for the chanty included for the chanty included for the chanty included in the accounts:
COmmitment~, M.t Thc Chanty hss no commitments, liabiliiies or provisions.
Liabilities and
Provisions
14.2 Thc Trustcc rccognisc liabilities in the accounts once they have incurred either a
legal or constructive
obligation
lo expend funds.
Trustee and 15
Conncctcd
Persons 15.1 Trustee expenses
reimbursed
2021-22 2020.21
Transactions f 6
Travel and subsistence 0
Entcrmrnmeut
Giber lplease descnbe)
Total number of Trust Board Members representing thc Tnmcc 13 13
15.2 There was no Trustee remuners(ion
15.3 There «ere no transact isns with a Trustee or caanectcd pe mons in any
pemonal capacity
154 Trustee Indemnity
Insurance
Cover provided
under Liverpool
University Hospimls NHS Foundation Trust's
Litiganon
Authonty
Non.clinical
rist scheme.

Name, nature ofconnection. 2021-22 2021-22 2020-21 2020-21
description ofactivities undertaken Turnover
of
Nct Prolit/ Turnover of Net Prof/1/
and details ofany qualifrcarious Connected (Loss) for Ihe Connected Lass for the
expressed
by their auditors
Organisation Connected Organisation Connemed
Organisation
f
Organisation
Livcrpooi University
Hospicals NHS FT
(formerly
Royal Liverpool rcBroedgrecn
1,153,353,000 (7,379,000) 1.109,384,000 1.410.000
Ltniv eraity Hospt tale NHS Trust)